|
US2020254212A1
|
|
Methods and systems for obtaining clinical samples
|
|
WO2019094624A2
|
|
Methods and devices for sample collection and stabilization
|
|
WO2018223067A1
|
|
Methods and compositions for superparamagnetic particles for nucleic acid extraction
|
|
WO2018144633A1
|
|
Methods and devices for improved signal detection from biological samples
|
|
US10301689B1
|
|
Methods and compositions for detection of Zika viral infections
|
|
US10401373B1
|
|
Systems and methods for analyte testing and laboratory oversight
|
|
US2017317903A1
|
|
Network connectivity methods and systems
|
|
US2017122846A1
|
|
Bodily fluid sample collection and transport
|
|
US10248765B1
|
|
Systems, devices, and methods for bodily fluid sample collection, transport, and handling
|
|
EP3025257A1
|
|
Systems and methods for a distributed clinical laboratory
|
|
US10441204B1
|
|
Methods for obtaining blood from a subject
|
|
CN109975071A
|
|
Systems, devices and methods for body fluid sample collection
|
|
AU2014233213A1
|
|
Thermostable blunt-end ligase and methods of use
|
|
AU2014233150A1
|
|
Nucleic acid amplification
|
|
MX368673B
|
|
Devices, systems and methods for sample preparation.
|
|
EP3595246A1
|
|
Network connectivity methods and systems
|
|
EP2928374A2
|
|
Device for bodily fluid sample collection
|
|
AU2013231105A1
|
|
Methods and systems for assessing clinical outcomes
|
|
CN111067547A
|
|
Systems, devices, and methods for bodily fluid sample collection
|
|
CN109547235A
|
|
Method for connecting network and system
|
